Clinical research leaders and teams will deepen their understanding of regulatory requirements and quality management practices that support compliance, oversight, and effective trial execution.

Regulatory & Quality Track

2027 Program
Advancing Pharmacy and Drug Management for Clinical Trial Participant Safety
Read more →
Audits Unplugged: Views from Both Sides of the Process
Read more →
Across the Aisle: Reaching Common Ground Between Principal Investigators and Institutional Review Boards
Read more →
Burnout as a Data Integrity Risk: A Structural Quality Intervention
Read more →
From Assembly Lines to Patient Visits: Why Clinical Trials Need "Factory Logic"
Read more →
When Corrective and Preventive Action Plans Fail: Fixing Repeat Findings
Read more →
Avoiding Study Start-Up Delays by Aligning IBC and IRB Oversight
Read more →
What Happens After FDA Inspections: How to Respond with Confidence
Read more →
ICH E6(R3) and Principal Investigator Oversight: Beyond the Delegation Log
Read more →
Preparing Sites for Monitoring, Audits, Inspections, and ICH E6(R3)
Read more →
2027 U.S. Regulatory Update
Read more →
ICH E6(R3) is Final—Are You Still Running an R2 Program? A Reality Check for Sponsors and CROs
Read more →
More Than Billing: Unlocking the Strategic Value of Coverage Analysis
Read more →
Protecting Vulnerable Populations in Research: Ethical and Practical Considerations in Pediatric versus Adult Participants
Read more →
Trials in Transition: What Actually Changed in the 2026 Regulatory Environment
Read more →
COMPLETE SCHEDULE
REGISTRATION DETAILS
CONFERENCE TRACKS